Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Faquin

Showing results (21-30 of 97) with videos related to

Pageof 10
Sort By:
Cancer Cytopathology|July 1, 2024
The power and pitfalls of using social media to study rare cancers: Facebook, X, and other platforms can aid patient education and recruitment efforts, though experts caution that studies can be methodologically limited and unrepresentativeBryn Nelson, William Faquin
Cancer Cytopathology|August 2, 2023
A disturbing link between cancer and suicide: As multiple studies point to an elevated suicide risk among patients with cancer, especially those with head and neck cancers, researchers are trying to reduce the dangerBryn Nelson, William Faquin
Cancer Cytopathology|March 7, 2024
Growing threats of a mass exodus in governmental public health: Recruitment and retention woes, a lack of sustained investment, and partisan harassment and attacks are creating a mounting crisis for public health efforts, including cancer preventionBryn Nelson, William Faquin
Cancer Cytopathology|April 7, 2024
Growing cancer risks on a warming planet: In this first of a two-part series on cancer and climate change, recent natural disasters highlight how global warming is increasing cancer risks and widening health disparitiesBryn Nelson, William Faquin
Cancer Cytopathology|January 3, 2025
Counseling gap may worsen endometrial cancer disparities in Black women: A study finds that women of Black or African ancestry have fewer cancer-associated genetic mutations than White women but less access to genetic counselingBryn Nelson, William Faquin
Cancer Cytopathology|March 4, 2025
How an epidemic of untreated malnutrition is worsening cancer: In this first of a two-part series on how nutrition can influence cancer, recent studies have underscored the imperative to identify and treat malnutrition as a serious-and preventable-risk factorBryn Nelson, William Faquin
Cancer Cytopathology|October 3, 2023
Understanding the "zombie cells" that won't die: Cell senescence is emerging as a highly complicated but newly energized front in the battle against cancerBryn Nelson, William Faquin
Cancer Cytopathology|June 2, 2023
Artificial intelligence and cytopathology: Where are we heading?: In this first of a two-part series, a recent burst of research in artificial intelligence is showing how the algorithms can expand beyond gynecologic applications-and how they might shift responsibilities for the cytology workforce: In this first of a two-part series, a recent burst of research in artificial intelligence is showing how the algorithms can expand beyond gynecologic applications-and how they might shift responsibilities for the cytology workforceBryn Nelson, William Faquin
Cancer Cytopathology|December 9, 2023
An uncertain balance: In search of the sweet spot for cancer screening: In this second of a two-part series on the struggle to balance preventive care costs and benefits, the lessons of thyroid cancer overdiagnosis and overtreatment highlight the difficulties surrounding evidence-based decisionsBryn Nelson, William Faquin
Cancer Cytopathology|March 2, 2023
The "preexisting condition" invention in American health care: The persistence of a potential insurance nightmare: In this first part of a two-part series, the uniquely American business model of private health insurance has excluded millions for reasons that have little to do with medicine or biology; the potential return of such exclusions could threaten some of medicine's biggest goals: In this first part of a two-part series, the uniquely American business model of private health insurance has excluded millions for reasons that have little to do with medicine or biology; the potential return of such exclusions could threaten some of medicine's biggest goalsBryn Nelson, William Faquin
Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
Cancer Cytopathology|July 1, 2024
The power and pitfalls of using social media to study rare cancers: Facebook, X, and other platforms can aid patient education and recruitment efforts, though experts caution that studies can be methodologically limited and unrepresentativeBryn Nelson, William Faquin
Cancer Cytopathology|August 2, 2023
A disturbing link between cancer and suicide: As multiple studies point to an elevated suicide risk among patients with cancer, especially those with head and neck cancers, researchers are trying to reduce the dangerBryn Nelson, William Faquin
Cancer Cytopathology|March 7, 2024
Growing threats of a mass exodus in governmental public health: Recruitment and retention woes, a lack of sustained investment, and partisan harassment and attacks are creating a mounting crisis for public health efforts, including cancer preventionBryn Nelson, William Faquin
Cancer Cytopathology|April 7, 2024
Growing cancer risks on a warming planet: In this first of a two-part series on cancer and climate change, recent natural disasters highlight how global warming is increasing cancer risks and widening health disparitiesBryn Nelson, William Faquin
Cancer Cytopathology|January 3, 2025
Counseling gap may worsen endometrial cancer disparities in Black women: A study finds that women of Black or African ancestry have fewer cancer-associated genetic mutations than White women but less access to genetic counselingBryn Nelson, William Faquin
Cancer Cytopathology|March 4, 2025
How an epidemic of untreated malnutrition is worsening cancer: In this first of a two-part series on how nutrition can influence cancer, recent studies have underscored the imperative to identify and treat malnutrition as a serious-and preventable-risk factorBryn Nelson, William Faquin
Cancer Cytopathology|October 3, 2023
Understanding the "zombie cells" that won't die: Cell senescence is emerging as a highly complicated but newly energized front in the battle against cancerBryn Nelson, William Faquin
Cancer Cytopathology|June 2, 2023
Artificial intelligence and cytopathology: Where are we heading?: In this first of a two-part series, a recent burst of research in artificial intelligence is showing how the algorithms can expand beyond gynecologic applications-and how they might shift responsibilities for the cytology workforce: In this first of a two-part series, a recent burst of research in artificial intelligence is showing how the algorithms can expand beyond gynecologic applications-and how they might shift responsibilities for the cytology workforceBryn Nelson, William Faquin
Cancer Cytopathology|December 9, 2023
An uncertain balance: In search of the sweet spot for cancer screening: In this second of a two-part series on the struggle to balance preventive care costs and benefits, the lessons of thyroid cancer overdiagnosis and overtreatment highlight the difficulties surrounding evidence-based decisionsBryn Nelson, William Faquin
Cancer Cytopathology|March 2, 2023
The "preexisting condition" invention in American health care: The persistence of a potential insurance nightmare: In this first part of a two-part series, the uniquely American business model of private health insurance has excluded millions for reasons that have little to do with medicine or biology; the potential return of such exclusions could threaten some of medicine's biggest goals: In this first part of a two-part series, the uniquely American business model of private health insurance has excluded millions for reasons that have little to do with medicine or biology; the potential return of such exclusions could threaten some of medicine's biggest goalsBryn Nelson, William Faquin
Pageof 10